

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of fibrinolysis (GO:0051918) | 9.04617729 |
| 2 | regulation of fibrinolysis (GO:0051917) | 8.61985400 |
| 3 | * regulation of protein activation cascade (GO:2000257) | 8.61693630 |
| 4 | * regulation of complement activation (GO:0030449) | 8.18034074 |
| 5 | * complement activation, alternative pathway (GO:0006957) | 7.70431728 |
| 6 | protein carboxylation (GO:0018214) | 7.50384068 |
| 7 | peptidyl-glutamic acid carboxylation (GO:0017187) | 7.50384068 |
| 8 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.09138399 |
| 9 | L-phenylalanine catabolic process (GO:0006559) | 7.09138399 |
| 10 | blood coagulation, intrinsic pathway (GO:0007597) | 6.64046458 |
| 11 | L-phenylalanine metabolic process (GO:0006558) | 6.59247870 |
| 12 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.59247870 |
| 13 | exogenous drug catabolic process (GO:0042738) | 6.10112018 |
| 14 | very-low-density lipoprotein particle assembly (GO:0034379) | 6.02243682 |
| 15 | epoxygenase P450 pathway (GO:0019373) | 5.89872440 |
| 16 | negative regulation of protein activation cascade (GO:2000258) | 5.88197512 |
| 17 | drug catabolic process (GO:0042737) | 5.84819650 |
| 18 | fibrinolysis (GO:0042730) | 5.79443423 |
| 19 | plasma lipoprotein particle remodeling (GO:0034369) | 5.76286324 |
| 20 | protein-lipid complex remodeling (GO:0034368) | 5.76286324 |
| 21 | macromolecular complex remodeling (GO:0034367) | 5.76286324 |
| 22 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.71751334 |
| 23 | plasma lipoprotein particle assembly (GO:0034377) | 5.66580504 |
| 24 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 5.66092207 |
| 25 | regulation of cholesterol esterification (GO:0010872) | 5.64781080 |
| 26 | low-density lipoprotein particle remodeling (GO:0034374) | 5.61891097 |
| 27 | omega-hydroxylase P450 pathway (GO:0097267) | 5.57750675 |
| 28 | cholesterol efflux (GO:0033344) | 5.57107675 |
| 29 | negative regulation of cholesterol transport (GO:0032375) | 5.48712427 |
| 30 | negative regulation of sterol transport (GO:0032372) | 5.48712427 |
| 31 | regulation of plasminogen activation (GO:0010755) | 5.47046357 |
| 32 | high-density lipoprotein particle remodeling (GO:0034375) | 5.33980959 |
| 33 | glyoxylate metabolic process (GO:0046487) | 5.32773303 |
| 34 | regulation of apoptotic cell clearance (GO:2000425) | 5.30485137 |
| 35 | intestinal cholesterol absorption (GO:0030299) | 5.21683388 |
| 36 | * protein activation cascade (GO:0072376) | 5.18412558 |
| 37 | cellular glucuronidation (GO:0052695) | 5.01410440 |
| 38 | protein-lipid complex assembly (GO:0065005) | 5.01170008 |
| 39 | urea metabolic process (GO:0019627) | 5.01012788 |
| 40 | ethanol oxidation (GO:0006069) | 4.97555343 |
| 41 | aromatic amino acid family catabolic process (GO:0009074) | 4.93339161 |
| 42 | acute-phase response (GO:0006953) | 4.93028481 |
| 43 | reverse cholesterol transport (GO:0043691) | 4.92155502 |
| 44 | * regulation of humoral immune response (GO:0002920) | 4.90987580 |
| 45 | plasma lipoprotein particle organization (GO:0071827) | 4.86223333 |
| 46 | negative regulation of blood coagulation (GO:0030195) | 4.73545413 |
| 47 | negative regulation of hemostasis (GO:1900047) | 4.73545413 |
| 48 | glucuronate metabolic process (GO:0019585) | 4.72500010 |
| 49 | uronic acid metabolic process (GO:0006063) | 4.72500010 |
| 50 | plasma lipoprotein particle clearance (GO:0034381) | 4.71551684 |
| 51 | phospholipid efflux (GO:0033700) | 4.70428638 |
| 52 | negative regulation of complement activation (GO:0045916) | 4.59299954 |
| 53 | protein-lipid complex subunit organization (GO:0071825) | 4.55415012 |
| 54 | * complement activation, classical pathway (GO:0006958) | 4.53169609 |
| 55 | nitrogen cycle metabolic process (GO:0071941) | 4.49062621 |
| 56 | * complement activation (GO:0006956) | 4.48622119 |
| 57 | positive regulation of blood coagulation (GO:0030194) | 4.48299690 |
| 58 | positive regulation of hemostasis (GO:1900048) | 4.48299690 |
| 59 | bile acid metabolic process (GO:0008206) | 4.41313277 |
| 60 | bile acid biosynthetic process (GO:0006699) | 4.37725914 |
| 61 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.34521356 |
| 62 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.34521356 |
| 63 | negative regulation of coagulation (GO:0050819) | 4.32817135 |
| 64 | urea cycle (GO:0000050) | 4.31678900 |
| 65 | imidazole-containing compound metabolic process (GO:0052803) | 4.27563212 |
| 66 | acylglycerol homeostasis (GO:0055090) | 4.24986937 |
| 67 | triglyceride homeostasis (GO:0070328) | 4.24986937 |
| 68 | negative regulation of wound healing (GO:0061045) | 4.24497983 |
| 69 | serine family amino acid catabolic process (GO:0009071) | 4.15970236 |
| 70 | glutamate metabolic process (GO:0006536) | 4.13568518 |
| 71 | positive regulation of coagulation (GO:0050820) | 4.11911129 |
| 72 | drug metabolic process (GO:0017144) | 4.11317301 |
| 73 | regulation of bile acid biosynthetic process (GO:0070857) | 4.04457192 |
| 74 | negative regulation of lipase activity (GO:0060192) | 4.04383434 |
| 75 | ethanol metabolic process (GO:0006067) | 4.03260321 |
| 76 | regulation of triglyceride catabolic process (GO:0010896) | 3.96910379 |
| 77 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.93121800 |
| 78 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.93121800 |
| 79 | bile acid and bile salt transport (GO:0015721) | 3.88246796 |
| 80 | opsonization (GO:0008228) | 3.87295057 |
| 81 | oxidative demethylation (GO:0070989) | 3.73645138 |
| 82 | lipoprotein metabolic process (GO:0042157) | 3.73002094 |
| 83 | glycine metabolic process (GO:0006544) | 3.72668119 |
| 84 | tyrosine metabolic process (GO:0006570) | 3.72610765 |
| 85 | polyketide metabolic process (GO:0030638) | 3.67118898 |
| 86 | doxorubicin metabolic process (GO:0044598) | 3.67118898 |
| 87 | daunorubicin metabolic process (GO:0044597) | 3.67118898 |
| 88 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.64274400 |
| 89 | acute inflammatory response (GO:0002526) | 3.63420780 |
| 90 | cholesterol homeostasis (GO:0042632) | 3.63064481 |
| 91 | sterol homeostasis (GO:0055092) | 3.57809693 |
| 92 | negative regulation of humoral immune response (GO:0002921) | 3.57658322 |
| 93 | * cytolysis (GO:0019835) | 3.56819644 |
| 94 | sterol transport (GO:0015918) | 3.54705881 |
| 95 | cholesterol transport (GO:0030301) | 3.54705881 |
| 96 | phospholipid homeostasis (GO:0055091) | 3.49843333 |
| 97 | positive regulation of extracellular matrix organization (GO:1903055) | 3.42375598 |
| 98 | flavonoid metabolic process (GO:0009812) | 3.32572441 |
| 99 | * regulation of acute inflammatory response (GO:0002673) | 3.32368190 |
| 100 | alpha-amino acid catabolic process (GO:1901606) | 3.31101420 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.65635501 |
| 2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.92936606 |
| 3 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.67470511 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.62536232 |
| 5 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.70625871 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.51710214 |
| 7 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.12615011 |
| 8 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 3.83518469 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.74053450 |
| 10 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.61332659 |
| 11 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 3.00082175 |
| 12 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.77880021 |
| 13 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.13394393 |
| 14 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.3437026 |
| 15 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.74767835 |
| 16 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.72751896 |
| 17 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.68197349 |
| 18 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.61988786 |
| 19 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.59014895 |
| 20 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.56492326 |
| 21 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.50179037 |
| 22 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.41858029 |
| 23 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.33211340 |
| 24 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.32899641 |
| 25 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.30733874 |
| 26 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.29141173 |
| 27 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.25566922 |
| 28 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.22660319 |
| 29 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.21464050 |
| 30 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.21108121 |
| 31 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.20740123 |
| 32 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.18256642 |
| 33 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.17686960 |
| 34 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.14099084 |
| 35 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.12209641 |
| 36 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.10524445 |
| 37 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.04069526 |
| 38 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.01854200 |
| 39 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.01015130 |
| 40 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.98650017 |
| 41 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.97936425 |
| 42 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.96509519 |
| 43 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.94761100 |
| 44 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.93628934 |
| 45 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.93536599 |
| 46 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.91484373 |
| 47 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.90435262 |
| 48 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.88466480 |
| 49 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.86128313 |
| 50 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.85127837 |
| 51 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.83996195 |
| 52 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.83945154 |
| 53 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.83443594 |
| 54 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.82255661 |
| 55 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.81892186 |
| 56 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.81519421 |
| 57 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.80626090 |
| 58 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.77971316 |
| 59 | TP53_16413492_ChIP-PET_HCT116_Human | 0.77625244 |
| 60 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.75464306 |
| 61 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.75288578 |
| 62 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.75267106 |
| 63 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.75097910 |
| 64 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.75068115 |
| 65 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.72492428 |
| 66 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.72474195 |
| 67 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.70815263 |
| 68 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.70784888 |
| 69 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.69704127 |
| 70 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.69492195 |
| 71 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.68464782 |
| 72 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.67785317 |
| 73 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.66511996 |
| 74 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.66509929 |
| 75 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.65743815 |
| 76 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.65339681 |
| 77 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.64363359 |
| 78 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.64324647 |
| 79 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.63957806 |
| 80 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.63763066 |
| 81 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.62916155 |
| 82 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.62916155 |
| 83 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.62546565 |
| 84 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.61896619 |
| 85 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.61497318 |
| 86 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.61367623 |
| 87 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.61122551 |
| 88 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.60160960 |
| 89 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 0.60089068 |
| 90 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.58800581 |
| 91 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.58251015 |
| 92 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.57213532 |
| 93 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.56891572 |
| 94 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.56818820 |
| 95 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.55772760 |
| 96 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.55378854 |
| 97 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.54761270 |
| 98 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.54430213 |
| 99 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.54230918 |
| 100 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.53312227 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.77746090 |
| 2 | MP0005365_abnormal_bile_salt | 5.93327367 |
| 3 | MP0005360_urolithiasis | 5.77858299 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 5.74252916 |
| 5 | MP0003195_calcinosis | 5.41271194 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 4.69032567 |
| 7 | MP0003252_abnormal_bile_duct | 4.20344499 |
| 8 | MP0001666_abnormal_nutrient_absorption | 3.69840340 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.58400453 |
| 10 | MP0002138_abnormal_hepatobiliary_system | 3.44259850 |
| 11 | MP0003868_abnormal_feces_composition | 3.23165152 |
| 12 | MP0003122_maternal_imprinting | 2.55066989 |
| 13 | MP0005332_abnormal_amino_acid | 2.19399665 |
| 14 | MP0010368_abnormal_lymphatic_system | 2.19240576 |
| 15 | MP0005408_hypopigmentation | 1.97063609 |
| 16 | MP0000609_abnormal_liver_physiology | 1.96361732 |
| 17 | MP0009840_abnormal_foam_cell | 1.96008910 |
| 18 | MP0003191_abnormal_cellular_cholesterol | 1.95043967 |
| 19 | MP0009697_abnormal_copulation | 1.93320139 |
| 20 | MP0002118_abnormal_lipid_homeostasis | 1.81430268 |
| 21 | MP0001915_intracranial_hemorrhage | 1.59330464 |
| 22 | MP0000566_synostosis | 1.46311839 |
| 23 | MP0001661_extended_life_span | 1.45036328 |
| 24 | MP0002132_abnormal_respiratory_system | 1.44562956 |
| 25 | MP0002876_abnormal_thyroid_physiology | 1.36579013 |
| 26 | MP0003806_abnormal_nucleotide_metabolis | 1.29880307 |
| 27 | MP0001764_abnormal_homeostasis | 1.29699129 |
| 28 | MP0002089_abnormal_postnatal_growth/wei | 1.25343522 |
| 29 | MP0005451_abnormal_body_composition | 1.22802878 |
| 30 | MP0004019_abnormal_vitamin_homeostasis | 1.21584636 |
| 31 | MP0000598_abnormal_liver_morphology | 1.19948105 |
| 32 | MP0000604_amyloidosis | 1.16302020 |
| 33 | MP0005319_abnormal_enzyme/_coenzyme | 1.06672292 |
| 34 | MP0005058_abnormal_lysosome_morphology | 1.04545970 |
| 35 | MP0003656_abnormal_erythrocyte_physiolo | 1.04074271 |
| 36 | MP0003123_paternal_imprinting | 1.03824787 |
| 37 | MP0005670_abnormal_white_adipose | 0.96590534 |
| 38 | MP0005464_abnormal_platelet_physiology | 0.95027496 |
| 39 | MP0005636_abnormal_mineral_homeostasis | 0.90537975 |
| 40 | MP0006054_spinal_hemorrhage | 0.90490477 |
| 41 | MP0009642_abnormal_blood_homeostasis | 0.89869318 |
| 42 | MP0004272_abnormal_basement_membrane | 0.86931512 |
| 43 | MP0009643_abnormal_urine_homeostasis | 0.85207685 |
| 44 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.83279396 |
| 45 | MP0003172_abnormal_lysosome_physiology | 0.83081045 |
| 46 | MP0003690_abnormal_glial_cell | 0.80761678 |
| 47 | MP0005084_abnormal_gallbladder_morpholo | 0.80403998 |
| 48 | MP0005409_darkened_coat_color | 0.79057160 |
| 49 | MP0002282_abnormal_trachea_morphology | 0.77869505 |
| 50 | MP0002971_abnormal_brown_adipose | 0.76195626 |
| 51 | MP0000639_abnormal_adrenal_gland | 0.75925463 |
| 52 | MP0008469_abnormal_protein_level | 0.70914140 |
| 53 | MP0005376_homeostasis/metabolism_phenot | 0.68380464 |
| 54 | MP0005167_abnormal_blood-brain_barrier | 0.67397652 |
| 55 | MP0002078_abnormal_glucose_homeostasis | 0.65474132 |
| 56 | MP0009763_increased_sensitivity_to | 0.65193076 |
| 57 | MP0005164_abnormal_response_to | 0.63685556 |
| 58 | MP0009780_abnormal_chondrocyte_physiolo | 0.63052574 |
| 59 | MP0005220_abnormal_exocrine_pancreas | 0.62886271 |
| 60 | MP0003121_genomic_imprinting | 0.59794150 |
| 61 | MP0005023_abnormal_wound_healing | 0.59655836 |
| 62 | MP0003632_abnormal_nervous_system | 0.58877413 |
| 63 | MP0005395_other_phenotype | 0.58732688 |
| 64 | MP0009053_abnormal_anal_canal | 0.54832075 |
| 65 | MP0003879_abnormal_hair_cell | 0.54416185 |
| 66 | MP0002168_other_aberrant_phenotype | 0.53438181 |
| 67 | MP0001324_abnormal_eye_pigmentation | 0.50890108 |
| 68 | MP0003011_delayed_dark_adaptation | 0.50244539 |
| 69 | MP0000920_abnormal_myelination | 0.49540250 |
| 70 | MP0005187_abnormal_penis_morphology | 0.49069913 |
| 71 | MP0009115_abnormal_fat_cell | 0.48246769 |
| 72 | MP0003890_abnormal_embryonic-extraembry | 0.48244593 |
| 73 | MP0003950_abnormal_plasma_membrane | 0.47947875 |
| 74 | MP0004883_abnormal_blood_vessel | 0.47781396 |
| 75 | MP0003943_abnormal_hepatobiliary_system | 0.47492281 |
| 76 | MP0002933_joint_inflammation | 0.44646894 |
| 77 | MP0001756_abnormal_urination | 0.44529835 |
| 78 | MP0003183_abnormal_peptide_metabolism | 0.43640807 |
| 79 | MP0003953_abnormal_hormone_level | 0.42226513 |
| 80 | MP0005448_abnormal_energy_balance | 0.42202168 |
| 81 | MP0003567_abnormal_fetal_cardiomyocyte | 0.41787447 |
| 82 | MP0005334_abnormal_fat_pad | 0.41311197 |
| 83 | MP0003878_abnormal_ear_physiology | 0.41166953 |
| 84 | MP0005377_hearing/vestibular/ear_phenot | 0.41166953 |
| 85 | MP0002909_abnormal_adrenal_gland | 0.41164358 |
| 86 | MP0005257_abnormal_intraocular_pressure | 0.40712923 |
| 87 | MP0003638_abnormal_response/metabolism_ | 0.40358276 |
| 88 | MP0002128_abnormal_blood_circulation | 0.39839617 |
| 89 | MP0003633_abnormal_nervous_system | 0.39675248 |
| 90 | MP0005410_abnormal_fertilization | 0.38286138 |
| 91 | MP0009384_cardiac_valve_regurgitation | 0.38045727 |
| 92 | MP0003631_nervous_system_phenotype | 0.37512623 |
| 93 | MP0003329_amyloid_beta_deposits | 0.37355817 |
| 94 | MP0000249_abnormal_blood_vessel | 0.35934153 |
| 95 | MP0005647_abnormal_sex_gland | 0.35506882 |
| 96 | MP0003115_abnormal_respiratory_system | 0.35109449 |
| 97 | MP0003941_abnormal_skin_development | 0.35037152 |
| 98 | MP0004264_abnormal_extraembryonic_tissu | 0.34491030 |
| 99 | MP0003699_abnormal_female_reproductive | 0.31220851 |
| 100 | MP0005076_abnormal_cell_differentiation | 0.30998366 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prolonged partial thromboplastin time (HP:0003645) | 9.18392630 |
| 2 | * Complement deficiency (HP:0004431) | 8.56861376 |
| 3 | Hypobetalipoproteinemia (HP:0003563) | 7.98327894 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.99613358 |
| 5 | Joint hemorrhage (HP:0005261) | 6.81875561 |
| 6 | * Abnormality of complement system (HP:0005339) | 6.55167282 |
| 7 | Abnormality of the common coagulation pathway (HP:0010990) | 6.42733694 |
| 8 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.34572173 |
| 9 | Glomerulonephritis (HP:0000099) | 6.12019720 |
| 10 | Conjugated hyperbilirubinemia (HP:0002908) | 5.83802960 |
| 11 | Systemic lupus erythematosus (HP:0002725) | 5.59099030 |
| 12 | Spontaneous abortion (HP:0005268) | 5.51286146 |
| 13 | Xanthomatosis (HP:0000991) | 5.07934394 |
| 14 | Hypolipoproteinemia (HP:0010981) | 4.74366495 |
| 15 | Intrahepatic cholestasis (HP:0001406) | 4.62328655 |
| 16 | Hypercholesterolemia (HP:0003124) | 3.94902165 |
| 17 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.84617304 |
| 18 | Nephritis (HP:0000123) | 3.82005182 |
| 19 | Hyperlipoproteinemia (HP:0010980) | 3.77862794 |
| 20 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.77333379 |
| 21 | Gingival bleeding (HP:0000225) | 3.75653532 |
| 22 | Abnormality of the intrinsic pathway (HP:0010989) | 3.54145407 |
| 23 | Epidermoid cyst (HP:0200040) | 3.49882713 |
| 24 | Fat malabsorption (HP:0002630) | 3.48286093 |
| 25 | Menorrhagia (HP:0000132) | 3.47260955 |
| 26 | Vascular calcification (HP:0004934) | 3.28411580 |
| 27 | Hemorrhage of the eye (HP:0011885) | 3.23333547 |
| 28 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.21689359 |
| 29 | Acanthocytosis (HP:0001927) | 3.09714221 |
| 30 | Thrombophlebitis (HP:0004418) | 2.99362499 |
| 31 | Osteomalacia (HP:0002749) | 2.98949135 |
| 32 | Hypoalphalipoproteinemia (HP:0003233) | 2.98736612 |
| 33 | Mitral stenosis (HP:0001718) | 2.95841568 |
| 34 | Purpura (HP:0000979) | 2.94924701 |
| 35 | Hepatocellular carcinoma (HP:0001402) | 2.89830773 |
| 36 | Cardiovascular calcification (HP:0011915) | 2.88637502 |
| 37 | Arthropathy (HP:0003040) | 2.58906464 |
| 38 | Generalized aminoaciduria (HP:0002909) | 2.54945389 |
| 39 | Rickets (HP:0002748) | 2.51879910 |
| 40 | Hyperglycinemia (HP:0002154) | 2.49667103 |
| 41 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.48244245 |
| 42 | Abnormal tarsal ossification (HP:0008369) | 2.48219901 |
| 43 | Hypophosphatemic rickets (HP:0004912) | 2.43026721 |
| 44 | Abnormality of methionine metabolism (HP:0010901) | 2.34968093 |
| 45 | Abnormality of carpal bone ossification (HP:0006257) | 2.28558289 |
| 46 | Myocardial infarction (HP:0001658) | 2.27406299 |
| 47 | Hyperammonemia (HP:0001987) | 2.26857965 |
| 48 | Enlarged kidneys (HP:0000105) | 2.22679765 |
| 49 | Skin nodule (HP:0200036) | 2.18359041 |
| 50 | Pulmonary embolism (HP:0002204) | 2.15531182 |
| 51 | Abnormality of glycine metabolism (HP:0010895) | 2.12907980 |
| 52 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.12907980 |
| 53 | Poikilocytosis (HP:0004447) | 2.10929990 |
| 54 | Facial shape deformation (HP:0011334) | 2.09801817 |
| 55 | Potter facies (HP:0002009) | 2.09801817 |
| 56 | Joint swelling (HP:0001386) | 2.07774494 |
| 57 | Flat acetabular roof (HP:0003180) | 2.05506295 |
| 58 | Deep venous thrombosis (HP:0002625) | 11.3787962 |
| 59 | Steatorrhea (HP:0002570) | 1.98007072 |
| 60 | Increased serum pyruvate (HP:0003542) | 1.97128257 |
| 61 | Abnormal delivery (HP:0001787) | 1.95322890 |
| 62 | Hyperglycinuria (HP:0003108) | 1.94521771 |
| 63 | Epistaxis (HP:0000421) | 1.92395751 |
| 64 | Abnormality of nucleobase metabolism (HP:0010932) | 1.89781985 |
| 65 | Small epiphyses (HP:0010585) | 1.88083340 |
| 66 | Broad alveolar ridges (HP:0000187) | 1.86304931 |
| 67 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.85117913 |
| 68 | Delayed CNS myelination (HP:0002188) | 1.84324516 |
| 69 | Abnormality of the nasal septum (HP:0000419) | 1.82618451 |
| 70 | Hyperbilirubinemia (HP:0002904) | 1.81551596 |
| 71 | Amyloidosis (HP:0011034) | 1.81233267 |
| 72 | Fair hair (HP:0002286) | 1.80167667 |
| 73 | Hypoglycemic coma (HP:0001325) | 1.78209161 |
| 74 | Abnormality of proline metabolism (HP:0010907) | 1.77133953 |
| 75 | Hydroxyprolinuria (HP:0003080) | 1.77133953 |
| 76 | Increased serum ferritin (HP:0003281) | 1.73781543 |
| 77 | Hepatoblastoma (HP:0002884) | 1.72055402 |
| 78 | Abnormality of the Achilles tendon (HP:0005109) | 1.70759645 |
| 79 | Abnormality of glycolysis (HP:0004366) | 1.70224253 |
| 80 | Bifid scrotum (HP:0000048) | 1.69723338 |
| 81 | Abnormal hand bone ossification (HP:0010660) | 1.68759406 |
| 82 | Abnormality of the lumbar spine (HP:0100712) | 1.65727439 |
| 83 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.65464905 |
| 84 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.65444989 |
| 85 | Neoplasm of the liver (HP:0002896) | 1.62839805 |
| 86 | Peritonitis (HP:0002586) | 1.62644838 |
| 87 | Abnormal ossification of hand bones (HP:0005921) | 1.61855213 |
| 88 | Abnormality of serum amino acid levels (HP:0003112) | 1.61366718 |
| 89 | Hyperphosphaturia (HP:0003109) | 1.58925583 |
| 90 | Scanning speech (HP:0002168) | 1.58174702 |
| 91 | Abnormality of iron homeostasis (HP:0011031) | 1.57945891 |
| 92 | Broad palm (HP:0001169) | 1.57623794 |
| 93 | Abnormal foot bone ossification (HP:0010675) | 1.55779595 |
| 94 | Esophageal varix (HP:0002040) | 1.54753663 |
| 95 | Widely patent fontanelles and sutures (HP:0004492) | 1.54669528 |
| 96 | Elevated alkaline phosphatase (HP:0003155) | 1.53958487 |
| 97 | Abnormality of urine glucose concentration (HP:0011016) | 1.53710435 |
| 98 | Glycosuria (HP:0003076) | 1.53710435 |
| 99 | Gangrene (HP:0100758) | 1.53659533 |
| 100 | Reduced antithrombin III activity (HP:0001976) | 1.50120977 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FGFR4 | 6.76920861 |
| 2 | FGFR3 | 5.04024222 |
| 3 | PIK3CA | 3.26686015 |
| 4 | ICK | 3.21661721 |
| 5 | WNK4 | 3.04413016 |
| 6 | ERN1 | 2.64398209 |
| 7 | CDK12 | 2.42113871 |
| 8 | FGFR2 | 2.35937220 |
| 9 | RIPK1 | 2.21298087 |
| 10 | AKT3 | 2.10671150 |
| 11 | TYRO3 | 2.09092403 |
| 12 | FGFR1 | 2.03104292 |
| 13 | PIK3CG | 1.99819905 |
| 14 | PDGFRA | 1.95523365 |
| 15 | LATS1 | 1.85379745 |
| 16 | PRKAA2 | 1.84331077 |
| 17 | NEK9 | 1.70201451 |
| 18 | TRIB3 | 1.61169665 |
| 19 | RET | 1.58887701 |
| 20 | WNK1 | 1.53044706 |
| 21 | MAPK11 | 1.49940985 |
| 22 | TGFBR2 | 1.46186443 |
| 23 | PKN2 | 1.43303913 |
| 24 | MAP3K2 | 1.34373330 |
| 25 | BRSK2 | 1.29989721 |
| 26 | ERBB2 | 1.21508610 |
| 27 | EIF2AK1 | 1.19697831 |
| 28 | SIK1 | 1.17780773 |
| 29 | PDPK1 | 1.14062737 |
| 30 | DYRK1B | 1.13855110 |
| 31 | TYK2 | 1.10194562 |
| 32 | PRKACG | 1.07014502 |
| 33 | SGK494 | 1.02676678 |
| 34 | SGK223 | 1.02676678 |
| 35 | CAMK1D | 1.02423543 |
| 36 | EPHA3 | 0.96737503 |
| 37 | SIK2 | 0.94689809 |
| 38 | PDK1 | 0.88826242 |
| 39 | NTRK3 | 0.87954075 |
| 40 | NLK | 0.87365135 |
| 41 | DDR2 | 0.87257012 |
| 42 | CSNK1E | 0.85958583 |
| 43 | STK39 | 0.85154137 |
| 44 | PRKAA1 | 0.84616437 |
| 45 | SGK3 | 0.83935493 |
| 46 | BCR | 0.83680028 |
| 47 | EEF2K | 0.82135303 |
| 48 | SGK2 | 0.80306971 |
| 49 | CSF1R | 0.80159103 |
| 50 | EPHA4 | 0.80066098 |
| 51 | MAP2K4 | 0.78917858 |
| 52 | MET | 0.78431963 |
| 53 | FGR | 0.78007907 |
| 54 | CAMKK2 | 0.77904214 |
| 55 | RPS6KB1 | 0.76728417 |
| 56 | IGF1R | 0.76428123 |
| 57 | MST1R | 0.75331332 |
| 58 | CAMK1G | 0.72050173 |
| 59 | FLT3 | 0.71080771 |
| 60 | SGK1 | 0.67847703 |
| 61 | CDK6 | 0.66734900 |
| 62 | CDK7 | 0.63954633 |
| 63 | BRD4 | 0.61020634 |
| 64 | BRSK1 | 0.60357904 |
| 65 | PRKCG | 0.60271220 |
| 66 | CSNK1D | 0.60047500 |
| 67 | MAP3K6 | 0.58913151 |
| 68 | MAPKAPK3 | 0.57604887 |
| 69 | ERBB4 | 0.56394713 |
| 70 | PRKCZ | 0.56209596 |
| 71 | EIF2AK3 | 0.53470092 |
| 72 | FER | 0.52696290 |
| 73 | PRKG1 | 0.51764015 |
| 74 | IRAK3 | 0.50911208 |
| 75 | CDC42BPA | 0.48168958 |
| 76 | KSR2 | 0.47155720 |
| 77 | PDGFRB | 0.46953973 |
| 78 | LATS2 | 0.46868193 |
| 79 | MAP3K7 | 0.45634714 |
| 80 | SCYL2 | 0.45490756 |
| 81 | SRC | 0.43674263 |
| 82 | NEK1 | 0.42924101 |
| 83 | MAP2K6 | 0.42795892 |
| 84 | MTOR | 0.42644834 |
| 85 | JAK1 | 0.41401231 |
| 86 | BCKDK | 0.41034053 |
| 87 | RPS6KA3 | 0.38480081 |
| 88 | MAP2K3 | 0.38384430 |
| 89 | PRKACB | 0.38010186 |
| 90 | CSNK2A1 | 0.36901759 |
| 91 | YES1 | 0.36709902 |
| 92 | MATK | 0.36394873 |
| 93 | CSNK2A2 | 0.35931266 |
| 94 | MAP3K5 | 0.35544446 |
| 95 | CDK4 | 0.35344093 |
| 96 | MELK | 0.34988390 |
| 97 | GSK3A | 0.32324635 |
| 98 | STK38L | 0.31981140 |
| 99 | CDK9 | 0.31060720 |
| 100 | EPHA2 | 0.30603724 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Complement and coagulation cascades_Homo sapiens_hsa04610 | 5.21215769 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 4.41390663 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.60626501 |
| 4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.28726752 |
| 5 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.02983678 |
| 6 | Retinol metabolism_Homo sapiens_hsa00830 | 2.91394848 |
| 7 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.84002922 |
| 8 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.52777352 |
| 9 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.52094183 |
| 10 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.50290498 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.48262008 |
| 12 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.45751023 |
| 13 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.43785397 |
| 14 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.38435929 |
| 15 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.23322262 |
| 16 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.22614085 |
| 17 | Histidine metabolism_Homo sapiens_hsa00340 | 2.09537594 |
| 18 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.03982999 |
| 19 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.92966969 |
| 20 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.87573818 |
| 21 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.79205036 |
| 22 | Bile secretion_Homo sapiens_hsa04976 | 1.78191951 |
| 23 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.72203704 |
| 24 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.71493717 |
| 25 | * Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.62568716 |
| 26 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.61176432 |
| 27 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.59961970 |
| 28 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.58757221 |
| 29 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.52155977 |
| 30 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.49435676 |
| 31 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.36749683 |
| 32 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.29604391 |
| 33 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.28805181 |
| 34 | Peroxisome_Homo sapiens_hsa04146 | 1.27525127 |
| 35 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.27474752 |
| 36 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.25098232 |
| 37 | ABC transporters_Homo sapiens_hsa02010 | 1.22194386 |
| 38 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.16846769 |
| 39 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.13008525 |
| 40 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.06923748 |
| 41 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.04837335 |
| 42 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.01740897 |
| 43 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.01397284 |
| 44 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.00749647 |
| 45 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.00539285 |
| 46 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.97452852 |
| 47 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.95820792 |
| 48 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.95421093 |
| 49 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.95303898 |
| 50 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.92697756 |
| 51 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.91372121 |
| 52 | * Prion diseases_Homo sapiens_hsa05020 | 0.87060382 |
| 53 | Carbon metabolism_Homo sapiens_hsa01200 | 0.79363128 |
| 54 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.79025500 |
| 55 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.78810515 |
| 56 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.76895423 |
| 57 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.66674727 |
| 58 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.64939070 |
| 59 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.60958841 |
| 60 | Lysine degradation_Homo sapiens_hsa00310 | 0.59445217 |
| 61 | Other glycan degradation_Homo sapiens_hsa00511 | 0.56534592 |
| 62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.49831116 |
| 63 | Insulin resistance_Homo sapiens_hsa04931 | 0.40753647 |
| 64 | Metabolic pathways_Homo sapiens_hsa01100 | 0.40167557 |
| 65 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.39969913 |
| 66 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.39446284 |
| 67 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.38785919 |
| 68 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.38752505 |
| 69 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.36563003 |
| 70 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.34279759 |
| 71 | * Pertussis_Homo sapiens_hsa05133 | 0.32523626 |
| 72 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.31161151 |
| 73 | Galactose metabolism_Homo sapiens_hsa00052 | 0.29643503 |
| 74 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.28682878 |
| 75 | Sulfur relay system_Homo sapiens_hsa04122 | 0.27290321 |
| 76 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.27178109 |
| 77 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.20003779 |
| 78 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.17804044 |
| 79 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.14772400 |
| 80 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.13062637 |
| 81 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.12496042 |
| 82 | Mineral absorption_Homo sapiens_hsa04978 | 0.10572202 |
| 83 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.10048104 |
| 84 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.08821808 |
| 85 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.07599021 |
| 86 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.06542051 |
| 87 | * Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.03601149 |
| 88 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.02140483 |
| 89 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.01059413 |
| 90 | Amoebiasis_Homo sapiens_hsa05146 | 0.00214456 |
| 91 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | -0.1560540 |
| 92 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.1530047 |
| 93 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1215406 |
| 94 | Folate biosynthesis_Homo sapiens_hsa00790 | -0.1039041 |
| 95 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | -0.0713321 |
| 96 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.0706003 |
| 97 | Circadian rhythm_Homo sapiens_hsa04710 | -0.0661864 |
| 98 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0362870 |
| 99 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.0088184 |
| 100 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0025803 |

